Recently, International Flavors & Fragrances (IFF) (NYSE: IFF) reported its financial results for the third quarter ending September 30, 2024, showcasing positive growth and optimism for the year ahead. The company reported sales of $2.9 billion, marking a 4% increase compared to the same period in the previous year. On a comparable basis, currency-neutral sales rose by 9%, driven by robust performance across various segments, including double-digit growth in Health & Biosciences and Scent, as well as high single-digit increases in Nourish and Pharma Solutions. Volume saw a notable high single-digit growth across all divisions.
In the Scent segment, third-quarter reported sales reached $613 million, with currency-neutral sales up by 10% on a comparable basis. This growth was fueled by double-digit increases in Consumer Fragrance and Fine Fragrance and a high single-digit rise in Fragrance Ingredients. The Scent segment’s adjusted operating EBITDA for the quarter was $127 million, yielding a margin of 20.7%, an increase of 7% on a comparable basis due to volume growth and productivity improvements.
IFF has revised its full-year 2024 expectations upward, now anticipating annual sales to be between $11.3 billion and $11.4 billion, compared to the previously projected range of $11.1 billion to $11.3 billion. Additionally, adjusted operating EBITDA is expected to reach the high end of the previously communicated guidance range of $2.1 billion to $2.17 billion, indicating continued momentum and a positive outlook for IFF’s financial performance.
